Cardima picks Stamford as training center
Cardima (Fremont, California), a company focused on the treatment of atrial fibrillation and manufacturer of the Cardima surgical ablation system, EP ablation system and the Pathfinder family of diagnostic microcatheters, reported the establishment of its surgical ablation training program and center of excellence at Stamford Hospital (Stamford, Connecticut), for the Cardima surgical ablation system.
The company said Li Poa, MD, chief of cardiothoracic surgery and cardiac surgery program director at Stamford Hospital and faculty member at Columbia University (New York), is one of the world’s leading authorities on surgical ablation for the treatment of atrial fibrillation.
Poa will head the Cardima center of excellence program at Stamford Hospital. He has conducted extensive work perfecting thorascopic surgical techniques, and will train cardiothoracic surgeons on using the Cardima system.
SpectraCell expands facilities
SpectraCell Laboratories (Houston) said it has doubled the size of its facilities. Recently, SpectraCell occupied a 20,000-square-foot building that was designed for it in 2005. The planned expansion added a second freestanding 20,000-square-foot building to the existing campus.
The new $3.5 million facility houses SpectraCell’s clinical laboratory operations, while the existing building maintains corporate, financial, marketing and administrative functions. The expansion was completed in October.
“Our business has grown at a strong pace over the past few years, as physicians are accepting what research has been demonstrating for a long time – that nutritional deficiencies directly impact health and wellness,” said CEO/chairman William Stanberry. “As more clients incorporate our specialized laboratory tests into their practices, their patient outcomes improve measurably. As a result, the number of tests performed by us each month has skyrocketed. We outgrew our current building in three years.”
Misonix expands into U.S. sales with SonicOne
Misonix (Farmingdale, New York), a maker of minimally invasive ultrasonic medical device technology, which, in Europe is used for the ablation of cancer and worldwide for other acute health conditions, reported the expansion of its new sales channel for the U.S. The company is assembling a team of about 25 contract sales agents that will sell Misonix-labeled product, on a commission-only basis, directly to hospitals and clinics throughout the U.S.
The SonicOne Wound Management System will be the first product sold by this new sales team. SonicOne is a tissue-specific wound cleansing and debridement system, effective for the removal of devitalized or necrotic tissue and fibrin deposits, which ensures progress toward patient healing.
Some 15 sales agents are now under contract and have completed training. Exclusive sales territories represented by these representatives include, among others, markets such as Atlanta, Charlotte, Chicago, Detroit, Houston, Miami, New Orleans, New York City and Orlando.
B. Braun Medical launches new website
B. Braun Medical (Bethlehem, Pennsylvania) has launched a new website exclusively devoted to products, services and educational and editorial information for ambulatory surgical centers (ASCs).
The new online resource, www.asc.bbraunusa.com, provides the ASC community with quick and easy access to B. Braun products that help deliver quality, effective and safe care to patients from pre-op to post-op and beyond.
“This new site takes our Sharing Expertise philosophy to a new level,” said Scott Quilty, VP OPM Division for B. Braun Medical. “Its focus on the surgery center industry accentuates our ongoing commitment to this important marketplace while allowing ASC managers to quickly locate product and best practice information.”